A drug marketed to wildland firefighters exposed to smoke or PFAS shows no evidence of being effective, leading the International Association of Firefighters and the Food and Drug Administration to warn against its use. The drug, called glutathione, is marketed to fire fighters to remove toxins, but the IAFF says there are no scientific studies showing it can reduce forever chemical levels or relieve occupational exposures. “Because glutathione …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.